RecruitingNot applicableNCT05558644
Characterisation of the Immune Infiltrate and Molecular Features of Thymic Epithelial Tumors Tumors (TETs) (IMMUNO-TET)
Studying Thymic epithelial neoplasm
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Institut Curie
- Principal Investigator
- Clémence BASSE, MDInstitut Curie Paris
- Intervention
- single arm for all patients(other)
- Enrollment
- 50 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2026
Study locations (3)
- Institut Curie Paris, Paris, France
- Institut Mutualiste Montsouris, Paris, France
- Hôpital FOCH, Suresnes, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05558644 on ClinicalTrials.govOther trials for Thymic epithelial neoplasm
Additional recruiting or active studies for the same condition.